Opportunity Information: Apply for PAR 21 238
The National Institutes of Health (NIH) announced this limited-competition grant opportunity (PAR-21-238) to help certain U.S.-based research institutions develop or renovate physical research space specifically to strengthen HIV/AIDS research capacity. The focus is on improving or building facilities that directly support HIV/AIDS research across a wide range of disciplines, including basic science, translational research, clinical research (as a research area supported by the space, though the FOA itself is marked "Clinical Trial Not Allowed"), and social and behavioral science. In practical terms, the money is meant for bricks-and-mortar type improvements and the specialized research environments needed to conduct modern HIV/AIDS research effectively, rather than funding stand-alone research projects.
A central purpose of the program is to direct infrastructure investments toward institutions that serve underrepresented and underserved populations and/or are located in Institutional Development Award (IDeA)-eligible states. The intent is capacity-building: strengthening the research environment at places that historically have had fewer resources for research infrastructure, so they can better participate in and contribute to the national HIV/AIDS research enterprise. At the same time, the announcement explicitly excludes research-intensive institutions, reinforcing that this opportunity is designed for institutions that are building or expanding their research footprint rather than those that already have extensive, well-funded research facilities.
The renovated or developed space must align with NIH-established HIV/AIDS research priorities. Applicants are expected to make a clear case that the proposed construction or renovation is tied to real, documented research needs, both current and anticipated. In other words, the application needs to show that the institution has an active or growing HIV/AIDS research program (or a credible plan to expand one) and that the requested facility improvements are necessary to support that program. The FOA frames this as a justification requirement: requests should be driven by research needs, not simply general campus upgrades, and the resulting space should be positioned to enable or accelerate HIV/AIDS research activities that match NIH priority areas.
Eligibility is limited to U.S. domestic organizations. The FOA lists eligible applicant types broadly (including public and state-controlled institutions of higher education, private institutions of higher education, and certain nonprofit organizations with or without 501(c)(3) status), but it also highlights particular institution categories that commonly serve underrepresented populations. These include Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs). Foreign institutions are not eligible, and foreign components are not allowed, including non-U.S. components of U.S. organizations as defined under the NIH Grants Policy Statement.
From a funding and administrative standpoint, this is a discretionary NIH grant under the health funding activity category (CFDA 93.352). The listed award ceiling is $2,000,000. The original closing date shown in the source information is January 6, 2022, and the FOA was created May 4, 2021. Because it is described as a limited competition, applicants should expect that NIH may restrict eligibility further (for example, by limiting the number of applications per institution or requiring specific institutional characteristics), so prospective applicants would need to consult the full FOA text for all restrictions, allowable and unallowable costs, and the specific application and review criteria tied to construction/renovation (C06) awards.
Overall, the opportunity is best understood as targeted infrastructure support: NIH is offering up to a defined cap to help eligible, non-research-intensive institutions in IDeA states or serving underserved populations modernize or expand HIV/AIDS research space, as long as the facility plans are well-justified, directly connected to HIV/AIDS research priorities, and designed to meet both present and future research demands.Apply for PAR 21 238
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Limited Competition: Development and Renovation of Research Space for HIV/AIDS Research at Institutions Serving Underrepresented Populations or Located in Institutional Development Award (IDeA)-eligible States (C06 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.352.
- This funding opportunity was created on 2021-05-04.
- Applicants must submit their applications by 2022-01-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $2,000,000.00 in funding.
- Eligible applicants include: Public and State controlled institutions of higher education, Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is this NIH grant opportunity (PAR-21-238) intended to support?
This limited-competition NIH funding opportunity is intended to help eligible U.S.-based research institutions develop or renovate physical research space to strengthen HIV/AIDS research capacity. The emphasis is on facilities and specialized research environments (bricks-and-mortar improvements) that directly support HIV/AIDS research, rather than funding stand-alone research projects.
What is the main goal of the program?
The central goal is capacity-building: directing research infrastructure investments toward institutions that serve underrepresented and underserved populations and/or are located in IDeA-eligible states, so they can strengthen their research environment and better contribute to the national HIV/AIDS research enterprise.
Is this funding for research projects or for facilities?
This opportunity is focused on facilities: developing or renovating physical research space and the specialized environments needed for modern HIV/AIDS research. It is not described as funding independent research projects.
What kinds of HIV/AIDS research can the space support?
The supported space can be designed to enable HIV/AIDS research across a broad range of disciplines, including basic science, translational research, clinical research (as a research area supported by the space), and social and behavioral science, as long as it aligns with NIH-established HIV/AIDS research priorities.
The FOA says "Clinical Trial Not Allowed." Does that mean clinical research is excluded?
The information provided indicates the FOA is marked "Clinical Trial Not Allowed," while also noting that clinical research is included as a research area the space may support. In practical terms, the opportunity is described as supporting facilities for HIV/AIDS research activities rather than proposing a clinical trial under this award.
Who is eligible to apply?
Eligibility is limited to U.S. domestic organizations. Eligible applicant types are listed broadly and include public and state-controlled institutions of higher education, private institutions of higher education, and certain nonprofit organizations with or without 501(c)(3) status.
Are certain types of institutions specifically emphasized?
Yes. The opportunity highlights institutions that commonly serve underrepresented populations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
Are institutions in IDeA-eligible states a focus of this program?
Yes. A central purpose is to target infrastructure support to institutions in Institutional Development Award (IDeA)-eligible states and/or institutions serving underrepresented and underserved populations.
Are research-intensive institutions eligible?
The announcement explicitly excludes research-intensive institutions, indicating this opportunity is designed for institutions that are building or expanding their research footprint rather than those with extensive, well-funded research facilities.
Are foreign organizations eligible to apply?
No. Foreign institutions are not eligible.
Are foreign components allowed (including non-U.S. components of U.S. organizations)?
No. Foreign components are not allowed, including non-U.S. components of U.S. organizations as defined under the NIH Grants Policy Statement.
What is the maximum award amount?
The listed award ceiling is $2,000,000.
What agency is offering this funding?
The funding is offered by the National Institutes of Health (NIH).
How is this funding categorized administratively?
It is described as a discretionary NIH grant under the health funding activity category, with CFDA 93.352.
When was the FOA created, and what closing date is shown?
The FOA is shown as created on May 4, 2021. The original closing date shown is January 6, 2022.
What does it mean that this is a "limited competition" opportunity?
Being described as a limited competition suggests NIH may restrict eligibility further than the broad applicant categories (for example, limits on the number of applications per institution or requirements tied to specific institutional characteristics). The full FOA text would contain the definitive restrictions and rules.
What must applicants demonstrate about the need for the facility project?
Applicants are expected to justify that the proposed development or renovation is tied to real, documented HIV/AIDS research needs, both current and anticipated. The request should be driven by research needs rather than general campus upgrades.
How should the proposed space relate to NIH HIV/AIDS research priorities?
The renovated or developed space must align with NIH-established HIV/AIDS research priorities. Applicants are expected to clearly connect facility plans to HIV/AIDS research activities that match NIH priority areas.
Does the institution need an existing HIV/AIDS research program to apply?
The information indicates the application should show the institution has an active or growing HIV/AIDS research program, or a credible plan to expand one, and that the facility improvements are necessary to support that program.
Can the project be positioned to support future research growth, not just current needs?
Yes. The FOA framing described here emphasizes documenting both present and future research demands, and showing how the facility will enable or accelerate HIV/AIDS research activities over time.
Is this funding intended for general campus modernization?
No. The request is expected to be justified by HIV/AIDS research needs, not by general campus upgrade goals.
Where can applicants find the definitive list of allowable and unallowable costs and review criteria?
The summary notes that prospective applicants would need to consult the full FOA text for all restrictions, allowable and unallowable costs, and the specific application and review criteria tied to construction/renovation (C06) awards.
What is the overall takeaway on who this opportunity is best suited for?
It is best suited for eligible, non-research-intensive U.S. institutions, particularly those in IDeA states and/or serving underserved populations, that need targeted infrastructure support to modernize or expand HIV/AIDS research space in ways that are clearly justified and aligned with NIH HIV/AIDS research priorities.
Browse more opportunities from the same category: Health
Next opportunity: AHRQ Mentored Career Enhancement Awards for Established Investigators in Patient-Centered Outcome Research (K18)
Previous opportunity: DATA ANALYTICS FOR AUTONOMOUS OPTIMIZATION AND CONTROL OF ACCELERATORS AND DETECTORS
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 21 238
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 21 238) also looked into and applied for these:
| Funding Opportunity |
|---|
| NeuroNEXT Clinical Trials (U01 Clinical Trial Optional) Apply for PAR 21 223 Funding Number: PAR 21 223 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) Apply for PAR 21 224 Funding Number: PAR 21 224 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Guinea Local Health System Strengthening Activity (LHSSA) Apply for RFI 675 21 LHSSA 02 Funding Number: RFI 675 21 LHSSA 02 Agency: Guinea USAID-Conakry Category: Health Funding Amount: Case Dependent |
| Consortium for Innovative HIV/AIDS Vaccine and Cure Research (UM1 Clinical Trial Not Allowed) Apply for RFA AI 21 039 Funding Number: RFA AI 21 039 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed) Apply for PAR 21 228 Funding Number: PAR 21 228 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| NINDS Exploratory Clinical Trials (U01 - Clinical Trial Required) Apply for PAR 21 236 Funding Number: PAR 21 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed) Apply for PA 21 235 Funding Number: PA 21 235 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Joint NINDS/NIMH Exploratory Neuroscience Research Grant (R21 Clinical Trial Optional) Apply for PA 21 219 Funding Number: PA 21 219 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Emerging Science and Technology in Transplantation (U01 Clinical Trial Not Allowed) Apply for RFA AI 21 016 Funding Number: RFA AI 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed) Apply for RFA HL 22 001 Funding Number: RFA HL 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for PAR 21 237 Funding Number: PAR 21 237 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 21 016 Funding Number: RFA RM 21 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| USAID Social and Behavior Change (SBC) MALARIA Program in Mozambique Apply for 72065621USAIDSBCMALARIA Funding Number: 72065621USAIDSBCMALARIA Agency: Mozambique USAID-Maputo Category: Health Funding Amount: $6,000,000 |
| Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) (D43 Clinical Trial Optional) Apply for PAR 21 230 Funding Number: PAR 21 230 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R01 Clinical Trial Optional) Apply for RFA MH 21 225 Funding Number: RFA MH 21 225 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Adapting Immunotherapy and Gene Editing Based Strategies for Targeting HIV Reservoirs in the CNS: Potential Benefits and Risks (R21 Clinical Trial Optional) Apply for RFA MH 21 226 Funding Number: RFA MH 21 226 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) Apply for RFA HL 22 010 Funding Number: RFA HL 22 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) Apply for RFA HL 22 011 Funding Number: RFA HL 22 011 Agency: National Institutes of Health Category: Health Funding Amount: $150,000 |
| NIA Postdoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F32 Clinical Trial Not Allowed) Apply for PAR 21 217 Funding Number: PAR 21 217 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed) Apply for PAR 21 220 Funding Number: PAR 21 220 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 21 238", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.